Daily Archives: April 7, 2016

Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease

Posted on April 7, 2016 by Rona Yaeger, Manish A. Shah, Vincent A. Miller, Judith R. Kelsen, Kai Wang, Zachary J. Heins, Jeffrey S. Ross, Yuting He, Eric Sanford, Rhonda K. Yantiss, Sohail Balasubramanian, Philip J. Stephens, Nikolaus Schultz, Moshe Oren, Laura Tang, David Kel

Patients with inflammatory bowel diseases, such as Crohn’s disease (CD) and ulcerative colitis (UC), are at increased risk for small bowel or colorectal cancers (colitis-associated cancers [CACs]). We compared the spectrum of genomic alterations in C… Continue reading →

Posted in News | Comments Off on Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease

Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease

Posted on April 7, 2016 by Rona Yaeger, Manish A. Shah, Vincent A. Miller, Judith R. Kelsen, Kai Wang, Zachary J. Heins, Jeffrey S. Ross, Yuting He, Eric Sanford, Rhonda K. Yantiss, Sohail Balasubramanian, Philip J. Stephens, Nikolaus Schultz, Moshe Oren, Laura Tang, David Kel

Patients with inflammatory bowel diseases, such as Crohn’s disease (CD) and ulcerative colitis (UC), are at increased risk for small bowel or colorectal cancers (colitis-associated cancers [CACs]). We compared the spectrum of genomic alterations in C… Continue reading →

Posted in News | Comments Off on Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Posted on April 7, 2016 by Mette Julsgaard, Lisbet A. Christensen, Peter R. Gibson, Richard B. Gearry, Jan Fallingborg, Christian L. Hvas, Bo M. Bibby, Niels Uldbjerg, William R. Connell, Ourania Rosella, Anne Grosen, Steven J. Brown, Jens Kjeldsen, Signe Wildt, Lise Svennings

Little is known about in utero exposure to and postnatal clearance of anti–tumor necrosis factor (anti-TNF) agents in neonates. We investigated the concentrations of adalimumab and infliximab in umbilical cord blood of newborns and rates of clearance… Continue reading →

Posted in News | Comments Off on Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Posted on April 7, 2016 by Mette Julsgaard, Lisbet A. Christensen, Peter R. Gibson, Richard B. Gearry, Jan Fallingborg, Christian L. Hvas, Bo M. Bibby, Niels Uldbjerg, William R. Connell, Ourania Rosella, Anne Grosen, Steven J. Brown, Jens Kjeldsen, Signe Wildt, Lise Svennings

Little is known about in utero exposure to and postnatal clearance of anti–tumor necrosis factor (anti-TNF) agents in neonates. We investigated the concentrations of adalimumab and infliximab in umbilical cord blood of newborns and rates of clearance… Continue reading →

Posted in News | Comments Off on Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection